CN104665922B - Marshall ligament absolute ethyl alcohol ablation system - Google Patents
Marshall ligament absolute ethyl alcohol ablation system Download PDFInfo
- Publication number
- CN104665922B CN104665922B CN201510087915.5A CN201510087915A CN104665922B CN 104665922 B CN104665922 B CN 104665922B CN 201510087915 A CN201510087915 A CN 201510087915A CN 104665922 B CN104665922 B CN 104665922B
- Authority
- CN
- China
- Prior art keywords
- catheter
- balloon
- marshall
- ablation
- mapping
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 85
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 210000003041 ligament Anatomy 0.000 title claims abstract description 30
- 239000000126 substance Substances 0.000 claims abstract description 45
- 238000013507 mapping Methods 0.000 claims abstract description 41
- 210000003462 vein Anatomy 0.000 claims abstract description 26
- 210000003748 coronary sinus Anatomy 0.000 claims abstract description 11
- 238000002583 angiography Methods 0.000 claims abstract description 7
- 210000003191 femoral vein Anatomy 0.000 claims abstract description 7
- 230000008859 change Effects 0.000 claims abstract description 6
- 238000003384 imaging method Methods 0.000 claims abstract description 6
- 210000004204 blood vessel Anatomy 0.000 claims description 18
- 239000002872 contrast media Substances 0.000 claims description 11
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 5
- 230000000903 blocking effect Effects 0.000 claims description 3
- 238000002627 tracheal intubation Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 abstract 1
- 239000010959 steel Substances 0.000 abstract 1
- 238000010586 diagram Methods 0.000 description 7
- 206010003658 Atrial Fibrillation Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001746 atrial effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000005248 left atrial appendage Anatomy 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Landscapes
- Surgical Instruments (AREA)
Abstract
本发明涉及Marshall韧带无水乙醇消融系统,包括:造影标测电生理导管、专用导引鞘管、导引钢丝、化学消融球囊导管。Marshall韧带无水乙醇消融系统,将造影标测电生理导管通过导引鞘管,经股静脉途径插入冠状静脉窦,记录冠状静脉电位,并进行逆行造影,显示Marshall静脉,沿造影标测电生理导管推送导引鞘管至冠状静脉开口,撤出造影标测电生理导管,沿导引鞘管中心腔送入导引钢丝进入到冠状静脉,并引导化学消融球囊进入到Marshall静脉。导引钢丝兼有记录Marshall电位的功能,记录消融前后电位变化,电极可设计成2mm间隙,共设计10个电极。而后用化学消融球囊导管通过其远端側孔腔注入无水乙醇,实施化学消融。
The invention relates to an anhydrous ethanol ablation system for Marshall ligament, comprising: an electrophysiological catheter for imaging mapping, a special guiding sheath, a guiding steel wire, and a chemical ablation balloon catheter. Marshall ligament anhydrous ethanol ablation system, the angiographic mapping electrophysiological catheter is inserted through the guide sheath into the coronary sinus through the femoral vein, the coronary venous potential is recorded, and retrograde angiography is performed to display the vein of Marshall, along the angiographic mapping electrophysiological The catheter pushes the guiding sheath to the opening of the coronary vein, withdraws the angiographic mapping electrophysiological catheter, sends a guide wire along the central lumen of the guiding sheath into the coronary vein, and guides the chemical ablation balloon into the vein of Marshall. The guide wire also has the function of recording Marshall potential, and records the potential change before and after ablation. The electrodes can be designed with a gap of 2 mm, and a total of 10 electrodes are designed. Then use the chemical ablation balloon catheter to inject absolute ethanol through its distal side cavity to implement chemical ablation.
Description
技术领域technical field
本发明涉及医学测量技术领域,尤其涉及Marshall韧带无水乙醇消融系统。The invention relates to the technical field of medical measurement, in particular to a Marshall ligament absolute ethanol ablation system.
背景技术Background technique
众所周知,心房颤动(简称房颤)是临床上最常见的持续性心律失常。现有的研究发现,心脏Marshall韧带(Ligament of Marshall,LOM)在房颤的发生和维持中发挥重要作用。As we all know, atrial fibrillation (abbreviated as atrial fibrillation) is the most common clinical sustained arrhythmia. Existing studies have found that the ligament of Marshall (LOM) plays an important role in the occurrence and maintenance of atrial fibrillation.
Marshall韧带是胚胎时期左上腔静脉退化后形成的纤维条索状结构,走行于左心耳和左侧肺静脉之间,其内含有小静脉(Marshall静脉)和心肌纤维(Marshall束)以及神经组织。Marshall静脉即左房斜静脉,它起源于左上、左下肺静脉之间,斜行向下,收纳左房后壁静脉血,以锐角汇入冠状静脉窦。Marshall束内的心肌细胞则被纤维结缔组织包绕,在Marshall静脉汇入冠状静脉窦处与冠状静脉窦的肌束及临近的心房肌直接连接。研究证实,Marshall韧带内可以记录到电活动,对房颤的促发和维持起重要作用,采用射频消融或无水乙醇灌注的方法损毁Marshall韧带内的肌束可以达到治疗房颤的目的。消融的关键部位是Marshall韧带与冠状静脉窦交接处,消融终点是Marshall韧带电位完全消失。此外,Marshall静脉内灌注无水乙醇还可显著提高二尖瓣峡部阻滞率,提高持续性房颤的导管消融成功率。The ligament of Marshall is a fibrous cord-like structure formed after the degeneration of the left superior vena cava during the embryonic period. It runs between the left atrial appendage and the left pulmonary vein, and contains small veins (Marshall veins), myocardial fibers (Marshall bundles) and nerve tissues. Marshall's vein is the left atrial oblique vein, which originates between the left upper and left lower pulmonary veins, runs obliquely downward, receives venous blood from the posterior wall of the left atrium, and flows into the coronary sinus at an acute angle. The cardiomyocytes in the bundle of Marshall are surrounded by fibrous connective tissue and directly connect with the muscle bundle of the coronary sinus and the adjacent atrial myocardium at the point where the vein of Marshall joins the coronary sinus. Studies have confirmed that electrical activity can be recorded in the ligament of Marshall, which plays an important role in the initiation and maintenance of atrial fibrillation. Radiofrequency ablation or ethanol perfusion can be used to damage the muscle bundles in the ligament of Marshall to achieve the purpose of treating atrial fibrillation. The key site of ablation is the junction of the Marshall ligament and the coronary sinus, and the end point of ablation is the complete disappearance of the potential of the Marshall ligament. In addition, Marshall's intravenous infusion of absolute ethanol can also significantly improve the rate of mitral valve isthmus block and improve the success rate of catheter ablation of persistent atrial fibrillation.
发明内容Contents of the invention
本发明所要解决的技术问题是针对现有技术的不足,提出Marshall韧带无水乙醇消融系统,能够准确迅速地定位Marshall静脉,并记录消融前后Marshall电位的变化,从而达到良好的诊断及治疗目的。The technical problem to be solved by the present invention is to address the deficiencies of the prior art, and propose a Marshall ligament absolute ethanol ablation system, which can accurately and quickly locate the Marshall vein, and record the change of Marshall potential before and after ablation, so as to achieve good diagnosis and treatment purposes.
为此目的,本发明提出了Marshall韧带无水乙醇消融系统,包括:造影标测电生理导管、专用导引鞘管、导引钢丝、化学消融球囊导管;For this purpose, the present invention proposes an anhydrous ethanol ablation system for Marshall's ligament, including: an electrophysiological catheter for imaging mapping, a special guide sheath, a guide wire, and a chemical ablation balloon catheter;
所述造影标测电生理导管,用于经股静脉插入冠状静脉窦,记录冠状静脉电位,并进行逆行造影,显示Marshall静脉;The angiographic mapping electrophysiological catheter is used to insert the coronary sinus through the femoral vein, record the coronary venous potential, and perform retrograde angiography to display the vein of Marshall;
所述专用导引鞘管,用于经股静脉途径插管至冠状静脉窦,并通过其中心腔送入化学消融球囊导管;The special guide sheath is used for intubation to the coronary sinus through the femoral vein, and the chemical ablation balloon catheter is sent through the central lumen;
所述导引钢丝,用于引导化学消融球囊进入到Marshall静脉,导丝兼有记录Marshall电位的功能,记录消融前后电位变化,其中,多个电极间为2mm间隙,共10个电极对;The guide wire is used to guide the chemical ablation balloon into the Marshall vein. The guide wire also has the function of recording the Marshall potential, and records the potential change before and after ablation. Among them, there are 2 mm gaps between multiple electrodes, and a total of 10 electrode pairs;
所述化学消融球囊导管,用于通过其近端側孔腔注入无水乙醇,实施化学消融,其中,所述化学消融球囊导管设置为3.5F;The chemical ablation balloon catheter is used to inject absolute ethanol through its proximal side cavity to perform chemical ablation, wherein the chemical ablation balloon catheter is set at 3.5F;
其中,所述造影标测电生理导管包括球囊、标测电极头端、球囊充气接头、造影剂接头、标测电极连接头、以及导管主管;Wherein, the contrast mapping electrophysiological catheter includes a balloon, a mapping electrode tip, a balloon inflation connector, a contrast agent connector, a mapping electrode connector, and a catheter main tube;
所述球囊充气接头连接球囊导气管上,所述球囊导气管连接在球囊上,所述造影剂接头与导管的造影腔连接在一起,所述标测电极连接头通过电极保护管到达电极头端的位置;The inflation joint of the balloon is connected to the air guide tube of the balloon, the air guide tube of the balloon is connected to the balloon, the joint of the contrast agent is connected with the contrast cavity of the catheter, and the connector of the mapping electrode passes through the electrode protection tube Reach the position of the electrode tip;
所述专用导引鞘管,用于导引化学消融球囊导管进入冠状静脉;The special guide sheath is used to guide the chemical ablation balloon catheter into the coronary vein;
所述化学消融球囊导管上的球囊充气接头连接球囊导气管上,所述球囊导气管连接在球囊上,化学消融接头与导管的消融腔连接在一起,所述消融腔上有两个或两个以上的喷射孔。球囊0102要比病患部位的血管内径粗,以达到阻断血流的目的。喷射孔0204为多个密排的结构,以使造影剂能顺利的打入血管内部。导管头端有个柔软头端0203以保证导管不会损伤血管。The balloon inflation joint on the chemical ablation balloon catheter is connected to the balloon air guide tube, the balloon air guide tube is connected to the balloon, the chemical ablation joint is connected to the ablation cavity of the catheter, and the ablation cavity has Two or more spray holes. The balloon 0102 is thicker than the inner diameter of the blood vessel at the diseased site, so as to block the blood flow. The ejection holes 0204 are multiple closely arranged structures so that the contrast agent can be injected into the blood vessel smoothly. The catheter tip has a soft tip 0203 to ensure that the catheter will not damage the blood vessel.
具体地,所述化学消融球囊导管包括导引钢丝和消融球囊导管。Specifically, the chemical ablation balloon catheter includes a guide wire and an ablation balloon catheter.
具体地,导引钢丝包括尾部连接器、导引钢丝主体以及头端电极。.Specifically, the guide wire includes a tail connector, a guide wire body, and a head-end electrode. .
具体地,所述球囊内径大于病患部位的血管内径,用于阻断血流。Specifically, the inner diameter of the balloon is larger than the inner diameter of the blood vessel at the diseased site, so as to block blood flow.
具体地,所述喷射孔为多个密排的结构,用于使造影剂打入血管内部。Specifically, the injection holes are a plurality of closely-packed structures for injecting the contrast agent into the inside of the blood vessel.
具体地,所述化学消融球囊导管的导管头端设置柔软头端,用于保护导管不会损伤血管。Specifically, the catheter tip of the chemical ablation balloon catheter is provided with a soft tip for protecting the catheter from damaging blood vessels.
具体地,所述造影腔上有两个或两个以上的喷射孔。Specifically, there are two or more injection holes on the contrast cavity.
具体地,所述标测电极连接头的每个芯脚对应一个电极。Specifically, each pin of the mapping electrode connector corresponds to one electrode.
具体地,所述电极通过导线与对应的所述标测电极连接头上的芯脚进行连接。Specifically, the electrodes are connected to the corresponding pins on the connecting head of the mapping electrode through wires.
具体地,所述电极之间的间距均等,其中,所述电极为两个或两个以上。Specifically, the spacing between the electrodes is equal, wherein there are two or more electrodes.
本发明涉及Marshall韧带无水乙醇消融系统,包括:造影标测电生理导管、专用导引鞘管、导引钢丝、化学消融球囊导管;Marshall韧带无水乙醇消融系统,将造影标测电生理导管通过导引鞘管,经股静脉途径插入冠状静脉窦,记录冠状静脉电位,并进行逆行造影,显示Marshall静脉,沿造影标测电生理导管推送导引鞘管至冠状静脉开口,撤出造影标测电生理导管,沿导引鞘管中心腔送入导引钢丝进入到冠状静脉,并引导化学消融球囊进入到Marshall静脉。导引钢丝兼有记录Marshall电位的功能,记录消融前后电位变化,电极可设计成2mm间隙,共设计10个电极。而后用化学消融球囊导管通过其远端側孔腔注入无水乙醇,实施化学消融。The invention relates to an anhydrous ethanol ablation system for Marshall ligament, comprising: an electrophysiological catheter for imaging mapping, a special guide sheath, a guide wire, and a chemical ablation balloon catheter; The catheter is passed through the guide sheath, inserted into the coronary sinus via the femoral vein, the coronary venous potential is recorded, and retrograde angiography is performed to display the vein of Marshall, the guide sheath is pushed along the angiographic mapping electrophysiological catheter to the coronary vein opening, and the angiography is withdrawn The electrophysiological catheter was mapped, a guide wire was sent along the center lumen of the guide sheath into the coronary vein, and a chemical ablation balloon was guided into the vein of Marshall. The guide wire also has the function of recording Marshall potential, and records the potential change before and after ablation. The electrodes can be designed with a gap of 2 mm, and a total of 10 electrodes are designed. Then use the chemical ablation balloon catheter to inject absolute ethanol through its distal side cavity to implement chemical ablation.
上述说明仅是本发明技术方案的概述,为了能够更清楚了解本发明的技术手段,而可依照说明书的内容予以实施,并且为了让本发明的上述和其它目的、特征和优点能够更明显易懂,以下特举本发明的具体实施方式。The above description is only an overview of the technical solution of the present invention. In order to better understand the technical means of the present invention, it can be implemented according to the contents of the description, and in order to make the above and other purposes, features and advantages of the present invention more obvious and understandable , the specific embodiments of the present invention are enumerated below.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. Those skilled in the art can also obtain other drawings based on these drawings without creative work.
通过参考附图会更加清楚的理解本发明的特征和优点,附图是示意性的而不应理解为对本发明进行任何限制,在附图中:The features and advantages of the present invention will be more clearly understood by referring to the accompanying drawings, which are schematic and should not be construed as limiting the invention in any way. In the accompanying drawings:
图1示出了本发明Marshall韧带无水乙醇消融系统中化学消融球囊导管与导引钢丝配合的结构示意图;Fig. 1 shows the schematic structural diagram of the coordination of the chemical ablation balloon catheter and the guide wire in the Marshall ligament absolute ethanol ablation system of the present invention;
图2示出了本发明Marshall韧带无水乙醇消融系统中化学消融球囊导管的结构示意图;Fig. 2 shows the structure diagram of the chemical ablation balloon catheter in the Marshall ligament absolute ethanol ablation system of the present invention;
图3示出了本发明Marshall韧带无水乙醇消融系统中导引钢丝的结构示意图;Fig. 3 shows the structure diagram of the guide wire in the Marshall ligament absolute ethanol ablation system of the present invention;
图4示出了本发明Marshall韧带无水乙醇消融系统中导引鞘管的结构示意图;Fig. 4 shows the structural representation of the guiding sheath in the absolute ethanol ablation system for Marshall's ligament of the present invention;
图5示出了本发明Marshall韧带无水乙醇消融系统中造影标测电生理导管的结构示意图;Fig. 5 shows a schematic structural diagram of the electrophysiological catheter for contrast mapping in the Marshall ligament absolute ethanol ablation system of the present invention;
图6示出了本发明Marshall韧带无水乙醇消融系统中造影标测电生理导管的尾部结构图;Fig. 6 shows the structure diagram of the tail of the contrast mapping electrophysiological catheter in the Marshall ligament absolute ethanol ablation system of the present invention;
图7示出了本发明Marshall韧带无水乙醇消融系统中造影标测电生理导管造影腔局部结构图。Fig. 7 shows a local structural diagram of the angiographic cavity of the electrophysiological catheter for contrast mapping in the absolute ethanol ablation system for Marshall's ligament of the present invention.
具体实施方式detailed description
下面将结合附图对本发明的实施例进行详细描述。以下实施例仅用于说明本发明,但不能用来限制本发明的范围。Embodiments of the present invention will be described in detail below with reference to the accompanying drawings. The following examples are only used to illustrate the present invention, but can not be used to limit the scope of the present invention.
为了更好的理解与应用本发明提出的Marshall韧带无水乙醇消融系统,以如下附图示例进行详细说明。In order to better understand and apply the Marshall ligament absolute ethanol ablation system proposed by the present invention, it will be described in detail with the following figures as examples.
如图1所示,本发明提供了Marshall韧带无水乙醇消融系统,包括:造影标测电生理导管、专用导引鞘管、导引钢丝、化学消融球囊导管。As shown in FIG. 1 , the present invention provides an anhydrous ethanol ablation system for Marshall ligament, including: an electrophysiological catheter for contrast-enhanced mapping, a special guide sheath, a guide wire, and a chemical ablation balloon catheter.
具体地,造影标测电生理导管包括球囊(102),标测电极头端(6),球囊充气接头(1),造影剂接头(2),标测电极连接头(3),导管主管(4)。Specifically, the contrast mapping electrophysiological catheter includes a balloon (102), a mapping electrode tip (6), a balloon inflation connector (1), a contrast agent connector (2), a mapping electrode connector (3), a catheter Supervisor (4).
进一步地,结合图2-5所示,球囊充气接头(1)连接球囊导气管(101)上,球囊导气管(101)链接在球囊(102)上,造影剂接头(2)与导管的造影腔(202)连接在一起,造影腔(202)上有两个或两个以上,即多个喷射孔(204),标测电极连接头(3)通过电极保护管(301)到达电极头端(6)的位置,其中,标测电极连接头(3)的每个芯脚对应一个电极(601),电极(601)通过导线(603)与对应的标测电极连接头(3)上的芯脚连接在一起,且电极(601)之间的间距为均等的,电极(601)可以为两个或两个以上。Further, as shown in Figures 2-5, the balloon inflation joint (1) is connected to the balloon airway (101), the balloon airway (101) is linked to the balloon (102), and the contrast medium joint (2) It is connected with the contrast cavity (202) of the catheter. There are two or more injection holes (204) on the contrast cavity (202), and the mapping electrode connector (3) passes through the electrode protection tube (301) Arrive at the position of the electrode tip (6), wherein each core pin of the mapping electrode connector (3) corresponds to an electrode (601), and the electrode (601) is connected to the corresponding mapping electrode connector ( 3) The core pins on the top are connected together, and the distance between the electrodes (601) is equal, and there can be two or more electrodes (601).
更进一步地,球囊(102)要比病患部位的血管内径粗,以达到阻断血流的目的,喷射孔(204)为多个密排的结构,以便造影剂能顺利的打入血管内部。Furthermore, the balloon (102) should be thicker than the inner diameter of the blood vessel at the diseased site to achieve the purpose of blocking blood flow, and the injection holes (204) are multiple densely packed structures so that the contrast agent can be smoothly injected into the blood vessel internal.
更进一步地,造影标测电生理导管还包括导管头端,设置圆滑的柔软头端(602)以保证导管不会损伤血管。Furthermore, the electrophysiological catheter for contrast-enhanced mapping also includes a catheter tip, and a smooth and soft tip (602) is provided to ensure that the catheter will not damage blood vessels.
本发明提出的Marshall韧带无水乙醇消融系统还包括:专用导引鞘管,用于导引化学消融球囊导管进入冠状静脉。The absolute ethanol ablation system for Marshall's ligament proposed by the present invention also includes: a special guide sheath used for guiding the chemical ablation balloon catheter into the coronary vein.
本发明提出的Marshall韧带无水乙醇消融系统还包括:化学消融球囊导管,具体地,化学消融球囊导管上的球囊充气接头(01)连接球囊导气管(0101)上,球囊导气管(0101)连接在球囊(0102)上;化学消融接头(2)与导管的消融腔(0202)连接在一起,消融腔(0202)上有两个或两个以上,即多个喷射孔(0204)。The Marshall ligament absolute ethanol ablation system proposed by the present invention also includes: a chemical ablation balloon catheter, specifically, the balloon inflation joint (01) on the chemical ablation balloon catheter is connected to the balloon air guide tube (0101), and the balloon guide The trachea (0101) is connected to the balloon (0102); the chemical ablation joint (2) is connected to the ablation cavity (0202) of the catheter, and there are two or more injection holes on the ablation cavity (0202) (0204).
更进一步地,球囊(0102)要比病患部位的血管内径粗,以达到阻断血流的目的,喷射孔(0204)为多个密排的结构,以使造影剂能顺利的打入血管内部。Furthermore, the balloon (0102) should be thicker than the inner diameter of the blood vessel at the diseased site to achieve the purpose of blocking blood flow, and the injection holes (0204) are multiple densely packed structures so that the contrast agent can be injected smoothly Inside the blood vessel.
更进一步地,化学消融球囊导管的导管头端设置柔软头端(0203)以保证导管不会损伤血管。Furthermore, the catheter tip of the chemical ablation balloon catheter is provided with a soft tip (0203) to ensure that the catheter will not damage blood vessels.
更进一步地,化学消融球囊导管包括导引钢丝和消融球囊导管,其中,导引钢丝包括尾部连接器、导引钢丝主体以及头端电极。Furthermore, the chemical ablation balloon catheter includes a guide wire and an ablation balloon catheter, wherein the guide wire includes a tail connector, a main body of the guide wire, and a tip electrode.
更进一步地,如图6所示为造影标测电生理导管的尾部结构图。导管主管4分别分出三个腔球囊充气接头1,造影剂接头2,标测电极连接头3,且如图7所示,造影剂腔202将造影剂201通过喷射孔204将造影剂喷射到血管内部,再通过X射线机进行造影,以确定血管内部构造情况。而后将造影标测电生理导管撤出血管,通入导引鞘管,并将导引钢丝通过导引鞘管的中心腔进入冠状静脉。进行化学消融。Furthermore, FIG. 6 is a structural diagram of the tail of the electrophysiological catheter for contrast-enhanced mapping. The main tube 4 of the catheter is divided into three chambers: the balloon inflation connector 1, the contrast agent connector 2, and the mapping electrode connector 3. As shown in FIG. Go to the inside of the blood vessel, and then use an X-ray machine to perform imaging to determine the internal structure of the blood vessel. Then, the angiographic mapping electrophysiological catheter is withdrawn from the blood vessel, passed into the guide sheath, and the guide wire is passed through the central lumen of the guide sheath into the coronary vein. Perform chemical ablation.
本发明涉及Marshall韧带无水乙醇消融系统,包括:造影标测电生理导管、专用导引鞘管、导引钢丝、化学消融球囊导管;Marshall韧带无水乙醇消融系统,将造影标测电生理导管通过导引鞘管,经股静脉途径插入冠状静脉窦,记录冠状静脉电位,并进行逆行造影,显示Marshall静脉,沿造影标测电生理导管推送导引鞘管至冠状静脉开口,撤出造影标测电生理导管,沿导引鞘管中心腔送入导引钢丝进入到冠状静脉,并引导化学消融球囊进入到Marshall静脉。导引钢丝兼有记录Marshall电位的功能,记录消融前后电位变化,电极可设计成2mm间隙,共设计10个电极。而后用化学消融球囊导管通过其远端側孔腔注入无水乙醇,实施化学消融。The invention relates to an anhydrous ethanol ablation system for Marshall ligament, comprising: an electrophysiological catheter for imaging mapping, a special guide sheath, a guide wire, and a chemical ablation balloon catheter; The catheter is passed through the guide sheath, inserted into the coronary sinus via the femoral vein, the coronary venous potential is recorded, and retrograde angiography is performed to display the vein of Marshall, the guide sheath is pushed along the angiographic mapping electrophysiological catheter to the coronary vein opening, and the angiography is withdrawn The electrophysiological catheter was mapped, a guide wire was sent along the center lumen of the guide sheath into the coronary vein, and a chemical ablation balloon was guided into the vein of Marshall. The guide wire also has the function of recording Marshall potential, and records the potential change before and after ablation. The electrodes can be designed with a gap of 2 mm, and a total of 10 electrodes are designed. Then use the chemical ablation balloon catheter to inject absolute ethanol through its distal side cavity to implement chemical ablation.
本发明的各个部件实施例可以以硬件实现,或者以在一个或者多个处理器上运行的软件模块实现,或者以它们的组合实现。本领域的技术人员应当理解,可以在实践中使用微处理器或者数字信号处理器(DSP)来实现根据本发明实施例设备中的一些或者全部部件的一些或者全部功能。本发明还可以实现为用于执行这里所描述的方法的一部分或者全部的设备或者系统程序(例如,计算机程序和计算机程序产品)。这样的实现本发明的程序可以存储在计算机可读介质上,或者可以具有一个或者多个信号的形式。这样的信号可以从因特网网站上下载得到,或者在载体信号上提供,或者以任何其他形式提供。The various component embodiments of the present invention may be implemented in hardware, or in software modules running on one or more processors, or in a combination thereof. Those skilled in the art should understand that a microprocessor or a digital signal processor (DSP) may be used in practice to implement some or all functions of some or all components in the device according to the embodiment of the present invention. The present invention can also be implemented as an apparatus or system program (eg, computer program and computer program product) for performing a part or all of the methods described herein. Such a program for realizing the present invention may be stored on a computer-readable medium, or may be in the form of one or more signals. Such a signal may be downloaded from an Internet site, or provided on a carrier signal, or provided in any other form.
本文中所称的“一个实施例”、“实施例”或者“一个或者多个实施例”意味着,结合实施例描述的特定特征、结构或者特性包括在本发明的至少一个实施例中。此外,请注意,这里“在一个实施例中”的词语例子不一定全指同一个实施例。Reference herein to "one embodiment," "an embodiment," or "one or more embodiments" means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Additionally, please note that examples of the word "in one embodiment" herein do not necessarily all refer to the same embodiment.
在此处所提供的说明书中,说明了大量具体细节。然而,能够理解,本发明的实施例可以在没有这些具体细节的情况下被实践。在一些实例中,并未详细示出公知的方法、结构和技术,以便不模糊对本说明书的理解。In the description provided herein, numerous specific details are set forth. However, it is understood that embodiments of the invention may be practiced without these specific details. In some instances, well-known methods, structures and techniques have not been shown in detail in order not to obscure the understanding of this description.
应该注意的是上述实施例对本发明进行说明而不是对本发明进行限制,并且本领域技术人员在不脱离所附权利要求的范围的情况下可设计出替换实施例。在权利要求中,不应将位于括号之间的任何参考符号构造成对权利要求的限制。单词“包含”不排除存在未列在权利要求中的元件或步骤。位于元件之前的单词“一”或“一个”不排除存在多个这样的元件。本发明可以借助于包括有若干不同元件的硬件以及借助于适当编程的计算机来实现。在列举了若干系统的单元权利要求中,这些系统中的若干个可以是通过同一个硬件项来具体体现。单词第一、第二、以及第三等的使用不表示任何顺序。可将这些单词解释为名称。It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design alternative embodiments without departing from the scope of the appended claims. In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. The word "comprising" does not exclude the presence of elements or steps not listed in a claim. The word "a" or "an" preceding an element does not exclude the presence of a plurality of such elements. The invention can be implemented by means of hardware comprising several distinct elements, and by means of a suitably programmed computer. In a unit claim enumerating several systems, several of these systems can be embodied by one and the same item of hardware. The use of the words first, second, and third, etc. does not indicate any order. These words can be interpreted as names.
此外,还应当注意,本说明书中使用的语言主要是为了可读性和教导的目的而选择的,而不是为了解释或者限定本发明的主题而选择的。因此,在不偏离所附权利要求书的范围和精神的情况下,对于本技术领域的普通技术人员来说许多修改和变更都是显而易见的。对于本发明的范围,对本发明所做的公开是说明性的,而非限制性的,本发明的范围由所附权利要求书限定。In addition, it should be noted that the language used in the specification has been chosen primarily for the purpose of readability and instruction rather than to explain or delimit the inventive subject matter. Accordingly, many modifications and alterations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the appended claims. With respect to the scope of the present invention, the disclosure of the present invention is intended to be illustrative rather than restrictive, and the scope of the present invention is defined by the appended claims.
虽然结合附图描述了本发明的实施方式,但是本领域技术人员可以在不脱离本发明的精神和范围的情况下做出各种修改和变型,这样的修改和变型均落入由所附权利要求所限定的范围之内。Although the embodiments of the present invention have been described in conjunction with the accompanying drawings, those skilled in the art can make various modifications and variations without departing from the spirit and scope of the present invention. within the bounds of the requirements.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510087915.5A CN104665922B (en) | 2015-02-26 | 2015-02-26 | Marshall ligament absolute ethyl alcohol ablation system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510087915.5A CN104665922B (en) | 2015-02-26 | 2015-02-26 | Marshall ligament absolute ethyl alcohol ablation system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104665922A CN104665922A (en) | 2015-06-03 |
CN104665922B true CN104665922B (en) | 2017-01-18 |
Family
ID=53301885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510087915.5A Expired - Fee Related CN104665922B (en) | 2015-02-26 | 2015-02-26 | Marshall ligament absolute ethyl alcohol ablation system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104665922B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106691438B (en) * | 2016-12-07 | 2022-05-31 | 首都医科大学附属北京安贞医院 | Whole-heart three-dimensional mapping system for complex arrhythmias |
FR3080774B1 (en) * | 2018-05-04 | 2022-07-15 | Univ Bordeaux | CATHETER, INFLATABLE BALLOON FOR CATHETHER |
CN109394211B (en) * | 2018-12-18 | 2021-08-06 | 新乡医学院 | A kind of preparation method of metal electrode for in vivo electrophysiological recording |
CN113288408A (en) * | 2021-06-02 | 2021-08-24 | 陕西省中医医院 | Catheter with side holes for Marshall vein ablation in atrial fibrillation radio frequency ablation |
CN114209416A (en) * | 2021-12-16 | 2022-03-22 | 深圳市赛诺思医疗科技有限公司 | Chemical ablation balloon catheter, chemical ablation combination product and ablation method |
CN115253070B (en) * | 2022-09-02 | 2023-01-24 | 首都医科大学附属北京安贞医院 | Bedside TVTP lead |
CN117281605A (en) * | 2023-10-11 | 2023-12-26 | 上海玄宇医疗器械有限公司 | Balloon catheter for marshall vein ablation and mapping |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002077A2 (en) * | 1992-07-15 | 1994-02-03 | Angelase, Inc. | Ablation catheter system |
EP0706345B1 (en) * | 1993-07-01 | 2003-02-19 | Boston Scientific Limited | Imaging, electrical potential sensing, and ablation catheters |
CN1942145A (en) * | 2004-04-19 | 2007-04-04 | 普罗里森姆股份有限公司 | Ablation devices with sensor structures |
EP2022397A1 (en) * | 2007-08-08 | 2009-02-11 | ProRhythm, Inc. | Miniature circular mapping catheter |
CN101919729A (en) * | 2010-09-10 | 2010-12-22 | 刘小平 | Temperature-controlled ablation device and use thereof |
CN102274018A (en) * | 2011-05-23 | 2011-12-14 | 成正辉 | Fast-switching and mapping catheter, and preparation method and application method thereof |
CN102368970A (en) * | 2009-03-31 | 2012-03-07 | 东丽株式会社 | Stirring method and ablation catheter system with balloon |
CN102427845A (en) * | 2009-05-19 | 2012-04-25 | 东丽株式会社 | Guide wire and ablation catheter system with balloon |
WO2012071058A1 (en) * | 2010-11-23 | 2012-05-31 | William Joseph Drasler | Venous heated ablation catheter |
CN202426651U (en) * | 2012-01-19 | 2012-09-12 | 洪浪 | Coronary vein mapping catheter |
WO2014026055A1 (en) * | 2012-08-09 | 2014-02-13 | Fractyl Laboratories Inc. | Ablation systems, devices and methods for the treatment of tissue |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6755822B2 (en) * | 2001-06-01 | 2004-06-29 | Cryocor, Inc. | Device and method for the creation of a circumferential cryogenic lesion in a pulmonary vein |
US20070232949A1 (en) * | 2006-03-31 | 2007-10-04 | Ep Medsystems, Inc. | Method For Simultaneous Bi-Atrial Mapping Of Atrial Fibrillation |
US8663190B2 (en) * | 2011-04-22 | 2014-03-04 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
-
2015
- 2015-02-26 CN CN201510087915.5A patent/CN104665922B/en not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994002077A2 (en) * | 1992-07-15 | 1994-02-03 | Angelase, Inc. | Ablation catheter system |
EP0706345B1 (en) * | 1993-07-01 | 2003-02-19 | Boston Scientific Limited | Imaging, electrical potential sensing, and ablation catheters |
CN1942145A (en) * | 2004-04-19 | 2007-04-04 | 普罗里森姆股份有限公司 | Ablation devices with sensor structures |
EP2022397A1 (en) * | 2007-08-08 | 2009-02-11 | ProRhythm, Inc. | Miniature circular mapping catheter |
CN102368970A (en) * | 2009-03-31 | 2012-03-07 | 东丽株式会社 | Stirring method and ablation catheter system with balloon |
CN102427845A (en) * | 2009-05-19 | 2012-04-25 | 东丽株式会社 | Guide wire and ablation catheter system with balloon |
CN101919729A (en) * | 2010-09-10 | 2010-12-22 | 刘小平 | Temperature-controlled ablation device and use thereof |
WO2012071058A1 (en) * | 2010-11-23 | 2012-05-31 | William Joseph Drasler | Venous heated ablation catheter |
CN102274018A (en) * | 2011-05-23 | 2011-12-14 | 成正辉 | Fast-switching and mapping catheter, and preparation method and application method thereof |
CN202426651U (en) * | 2012-01-19 | 2012-09-12 | 洪浪 | Coronary vein mapping catheter |
WO2014026055A1 (en) * | 2012-08-09 | 2014-02-13 | Fractyl Laboratories Inc. | Ablation systems, devices and methods for the treatment of tissue |
Also Published As
Publication number | Publication date |
---|---|
CN104665922A (en) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104665922B (en) | Marshall ligament absolute ethyl alcohol ablation system | |
Dave et al. | Role of the vein of Marshall in atrial fibrillation recurrences after catheter ablation: therapeutic effect of ethanol infusion | |
JP6405090B2 (en) | Medical system for tracking the position of a medical device within a patient's vasculature and method for operating the medical system | |
US20200046965A1 (en) | Method for positioning terminal end of pacemaker lead, which has passed through coronary sinus, in interventricular septum | |
Abraham et al. | Cardiac pressure-volume loop analysis using conductance catheters in mice | |
Min et al. | Ultrasound-guided vs. palpation-guided techniques for radial arterial catheterisation in infants: a randomised controlled trial | |
Carrigan et al. | Anatomic relationships between the coronary venous system, surrounding structures, and the site of origin of epicardial ventricular arrhythmias | |
Crisóstomo et al. | Development of a closed chest model of chronic myocardial infarction in Swine: magnetic resonance imaging and pathological evaluation | |
Clauss et al. | Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure | |
Lee et al. | Radiofrequency catheter ablation targeting the vein of Marshall in difficult mitral isthmus ablation or pulmonary vein isolation | |
CN104644157B (en) | Special sacculus radiography electrophysiological mapping catheter for CRT (Cardiac Resynchronization Therapy) | |
Calligaris et al. | Cardiac stress test induced by dobutamine and monitored by cardiac catheterization in mice | |
Aryana et al. | Epicardial approach for cardiac electrophysiology procedures | |
CN204671267U (en) | Melt major part and ablating device | |
Yao et al. | Transesophageal echocardiography guided cannulation for peripheral cardiopulmonary bypass during robotic cardiac surgery | |
CN219185515U (en) | Cardiac Vein Chemical Ablation Kit | |
CN104984478A (en) | Vein tear sheath tube | |
Marum et al. | Pulmonary delivery of metoprolol reduces ventricular rate during atrial fibrillation and accelerates conversion to sinus rhythm | |
CN207755623U (en) | One boar jugular vein is intubated | |
CN207575528U (en) | L head dummy cerebral angiography Multifunctional catheters | |
CN207575529U (en) | J head dummy cerebral angiography Multifunctional catheters | |
Liu et al. | Comparative study between original and traditional method in establishing a chronic sinus node damage model in rabbit | |
CN221411959U (en) | Marshall ligament chemical ablation device | |
JP5976973B1 (en) | Peripheral blood vessel guide catheter with multipolar electrodes | |
Meyer et al. | Esophageal assessments of left ventricular filling pressures: A proof-of-concept study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170118 |